affordable steroids may be some COVID-19 reduced deaths by a third, says the World Health Organization

affordable steroids may be some COVID-19 reduced deaths by a third, says the World Health Organization

You would think that a strong immune system would have something very valuable when fighting COVID-19 and much of the time. But in the most extreme cases, refer to the World Health Organization (WHO) labels as “difficult and critical,” the most seriously ill, usually in hospital patients at highest risk of death system the body from disease should protect worse, it can lead to inflammation and other damage to the lungs, which can result in a case often fatal syndrome of acute respiratory distress syndrome (ARDS). Found in June a large study involving more than 6,200 patients at least that corticosteroids may prevent some cases of ARDS related crown and the consequent deaths, a class of drugs that reduce inflammation. Today, the WHO confirmed that the preliminary report released a new political ad on the basis of a study in JAMA that call for the administration of steroids for all patients in the category “serious and critical”, based on the results that could reduce mortality treatment of little more than a third. The new results were achieved through a meta-analysis of seven studies, each exploring the efficacy of corticosteroids in most severe cases of COVID-19 The combined sample from all seven studies included 1,703 critically ill patients, 678 of whom are They were administered steroids and 1,025 who received usual care or placebo (non-steroids included). All patients were hospitalized and most were on ventilators. During 28 days, the mortality rate was 34% among patients treated with steroids lower than those of the control group. “The results are consistent beneficial in these studies provide definitive data are available that corticosteroids should for critically ill patients with COVID-19, the first-line therapy to be,” wrote Dr. Hallie Prescott, professor of medicine at the University of Michigan and Dr. Todd Rice, professor of medicine at Vanderbilt University, who accompanied the publication of the study in an editorial in JAMA. The results are limited. Steroids should not be used prophylactically in people with less severe cases of COVID-19, as the same oppression prevent the action of the immune system that the immune system would be their only worsen the condition of people or treating ARDS help function as they should fight the virus without damaging the lungs. WHO also against “the indiscriminate use,” it warned to create any anti-COVID-19 therapy, including steroids, for fear of global scarcity. A new therapy that 34% have actually made it sick for a subset of cases of a disease that nearly 26 million people around the world, is not the stuff of which the victory parade. But in the grinding war against COVID-19, it is an indisputable victory in a major fight.
Picture copyright by Niall Carson Press Association / AP